Beta Bionics Announces Participation at Upcoming Investor Conferences
Rhea-AI Summary
Beta Bionics (Nasdaq: BBNX), a leader in advanced diabetes management solutions, has announced its participation in three major healthcare investor conferences in September 2025. The company will present at the Wells Fargo Healthcare Conference (September 4), Morgan Stanley Global Healthcare Conference (September 8), and Baird Global Healthcare Conference (September 10).
Live webcasts will be available for the Wells Fargo and Morgan Stanley presentations through the company's investor relations website, where recordings will also be archived for future viewing.
Positive
- None.
Negative
- None.
IRVINE, Calif., Aug. 21, 2025 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today announced that management will present at three upcoming investor conferences (all Eastern Time):
- Wells Fargo 20th Annual Healthcare Conference on Thursday, September 4, 2025 at 3:45pm
- Morgan Stanley 23rd Annual Global Healthcare Conference on Monday, September 8, 2025 at 1:50pm
- Baird 2025 Global Healthcare Conference on Wednesday, September 10, 2025 at 9:40am
The presentations at the Wells Fargo and Morgan Stanley conferences will be webcast live. The link to the webcasts will be available on the Company’s website in the “Investors—Events & Presentations” section at https://investors.betabionics.com, and will be archived there for future replay following the events.
About Beta Bionics
Beta Bionics, Inc. is a commercial-stage medical device company engaged in the design, development, and commercialization of innovative solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing advanced adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The iLet Bionic Pancreas is the first FDA-cleared insulin delivery device that autonomously determines every insulin dose and offers the potential to substantially improve overall outcomes across broad populations of PWD. To learn more, visit www.betabionics.com.
Investor Relations:
Blake Beber
Head of Investor Relations
ir@betabionics.com
Media and Public Relations:
Karen Hynes
Vice President of Marketing
media@betabionics.com
Source: Beta Bionics, Inc.
FAQ
When is Beta Bionics (BBNX) presenting at the Wells Fargo Healthcare Conference 2025?
How can investors watch Beta Bionics' (BBNX) conference presentations?
What upcoming investor conferences will Beta Bionics (BBNX) attend in September 2025?
What time is Beta Bionics' (BBNX) presentation at the Morgan Stanley Healthcare Conference?
